No Detail Found!

Comparison of clinicopathological and survival analysis of endometrial dedifferentiated, undifferentiated carcinomas and carcinosarcomas

Author(s)
Usman Hassan Shaukat Khanum Memorial Cancer Hospital and Research Center,Lahore-,Pakistan
Iram Asrar Shaukat Khanum Memorial Cancer Hospital and Research Center,Lahore-,Pakistan
Hina Maqbool Shaukat Khanum Memorial Cancer Hospital and Research Center,Lahore-,Pakistan
Mudassar Hussain Shaukat Khanum Memorial Cancer Hospital and Research Center,Lahore-,Pakistan
Maryam Hameed Shaukat Khanum Memorial Cancer Hospital and Research Center,Lahore-,Pakistan
Asif Loya Shaukat Khanum Memorial Cancer Hospital and Research Center,Lahore-,Pakistan
Abstract
Background: Endometrial cancer ranks as the sixth frequently detected cancer and the 14th highest contributor, to cancer-related fatalities, among women globally. High-grade endometrial carcinomas encompass a diverse array of clinically aggressive tumours, including FIGO grade 3 endometrioid adenocarcinoma, uterine papillary serous carcinoma (UPSC), clear cell carcinoma, undifferentiated carcinoma, dedifferentiated carcinoma, and carcinosarcoma. The classification and diagnosis of these tumours pose challenges due to the absence of well-established molecular markers or panels. The main purpose of this study is to assess and compare the clinicopathological characteristics of and survival rates of undifferentiated endometrial carcinoma (UEC), dedifferentiated carcinoma (DEC), and carcinosarcoma (CS) in the Pakistani population at SKMCH&RC. Methods: All patients diagnosed with DEC, UEC, and CS were analyzed from January 2011 and December 2022. Clinicopathological and survival data was retrospectively reviewed and analyzed using SPSS version 27. Kaplan-Meier analysis was used to calculate overall survival (OS) and disease-free survival (DFS). Results: Among 71 selected patients, 47.9% had CS, 29.6% had DEC, and 22.5% had UEC. Mean±SD age at diagnosis was 58.18±11.35 years. A statistically significant association of DEC, UEC, and CS was identified (p-value <0.05) with myometrial invasion (p=0.02), lymphovascular invasion(p=0.006), positive margins(p=0.003), and involvement of adnexa/ parametria/ vaginal /adnexa/ parametria/ vaginal /another organ (p=0.01). The commonest pathological stage was pT1 38(53.5%). 56.3% of patients received chemotherapy, 29.6% received radiotherapy, and 38.0% received a combination of chemotherapy and radiation treatment. Recurrence occurred in 19.7% and death occurred in 37.7% of patients. The highest 5-year OS rate for pathological stage 1 was 59.1% (95% C.I: 42.9-81.3%) and 5-year-DFS was 62.2% (95% C.I: 42.9-81.3%). Conclusion: Patients diagnosed at an early pathological stage demonstrate better survival outcomes compared to an advanced stage, as documented in previous studies. Nevertheless, survival rates remain lower than Western population, indicating a necessity for gathering additional clinical data and alter the management strategies in our population.
Publication Details
Page(s) 596-605
Published Journal: Journal of Ayub Medical College, Volume: 36, Issue: 3, Year: 2024

Request the full text from PASTIC

Keywords
endometrial carcinoma, Clinicopathological, Undifferentiated, Highgrade, Carcinosarcoma, Dedifferentiated
References
Lortet-Tieulent J,Ferlay J,Bray F,Jemal A .2018 .International patterns and trends in endometrial cancer incidence,. J Natl Cancer Inst, 110(4) : 354-61.
Kobayashi Y,Kitazono I,Akahane T,Yanazume S,Kamio M,Togami S .2021 .Molecular evaluation of endometrial dedifferentiated carcinoma, endometrioid carcinoma, carcinosarcoma, and serous carcinoma using a custom-made small cancer panel. Pathol Oncol Res, 27 : 1610013.
Huvila J,Pors J,Thompson EF,Gilks CB .2021 .Endometrial carcinoma: molecular subtypes, precursors and the role of pathology in early diagnosis. J Pathol, 253(4) : 355-65.
Santoro A,Angelico G,Travaglino A,Inzani F,Arciuolo D,Valente M .2021 .New pathological and clinical insights in endometrial cancer in view of the updated ESGO/ESTRO/ESP guidelines. Cancers, 13(11) : 2623.
Kasius JC,Pijnenborg JM,Lindemann K,Forsse D,van Zwol J,Kristensen GB .2021 .Risk stratification of endometrial cancer patients: FIGO stage, biomarkers and molecular classification. Cancers, 13(22) : 5848.
Hamilton SN,Tinker AV,Kwon J,Lim P,Kong I,Sihra S .2022 .Treatment and outcomes in undifferentiated and dedifferentiated endometrial carcinoma. J Gynecol Oncol, 33(3) : e25.
Li Z,Zhao C .2016 .Clinicopathologic and immunohistochemical characterization of dedifferentiated endometrioid adenocarcinoma. Appl Immunohistochem Mol Morphol, 24(8) : 562-8.
Bansal N,Herzog TJ,Seshan VE,Schiff PB,Burke WM,Cohen CJ .2008 .Uterine carcinosarcomas and grade 3 endometrioid cancers: evidence for distinct tumour behavior. Obstet Gynecol, 112(1) : 64-70.
Lakhwani P,Agarwal P,Goel A,Nayar N,Pande P,Kumar K.,High-Grade Endometrial K. .2019 .Outcomes at a Tertiary Cancer Centre. Indian J Surg Oncol, 10(4) : 662-7.
Murali R,Davidson B,Fadare O,Carlson JA,Crum CP,Gilks CB .2019 .High-grade endometrial carcinomas: morphologic and immunohistochemical features, diagnostic challenges and recommendations. Int J Gynecol Pathol, 38(Suppl 1) : S40-63.
Taskin OÇ,Onder S,Topuz S,Sozen H,Sen F,Ilhan R .2017 .A selected immunohistochemical panel aids in differential diagnosis and prognostic stratification of subtypes of highgrade endometrial carcinoma: a clinicopathologic and immunohistochemical study at a single institution. Appl Immunohistochem Mol Morphol, 25(10) : 696-702.
Paulino E .2023 .Clinical Characteristics and Outcomes of a High-grade Endometrial Cancer Cohort Treated. Brazil. Rev Bras Ginecol Obstet, 45(7) : e401-8.
Ercelep O,Gumus M. .2019 .Comparison of clinicopathologic and survival characteristics of high-grade endometrial cancers; single center experience. Curr Probl Cancer, 43(2) : 160-6.
Silva EG,Deavers MT,Bodurka DC,Malpica A .2006 .Association of low-grade endometrioid carcinoma of the uterus and ovary with undifferentiated carcinoma: a new type of dedifferentiated carcinoma?. Int J Gynecol Pathol, 25(1) : 52-8.
Zhang K,Liu Y,Liu X,Du J,Wang Y,Yang J .2021 .Clinicopathological significance of multiple molecular features in undifferentiated and dedifferentiated endometrial carcinomas. Pathology, 53(2) : 179-86.
Scharl S,Sprötge T,Gerken M,Scharl A,Ortmann O,Kölbl O .2023 .Guideline concordant therapy improves survival in high-grade endometrial cancer patients. J Cancer Res Clin Oncol, 149(8) : 4761-9.
Sohaib SA,Houghton SL,Meroni R,Rockall AG,Blake P,Reznek RH .2007 .Recurrent endometrial cancer: patterns of recurrent disease and assessment of prognosis. Clin Radiol, 62(1) : 28-34.
Tafe LJ,Garg K,Chew I,Tornos C,Soslow RA .2010 .Endometrial and ovarian carcinomas with undifferentiated components: clinically aggressive and frequently underrecognized neoplasms. Mod Pathol, 23(6) : 781-9.
Altrabulsi B,Malpica A,Deavers MT,Bodurka DC,Broaddus R,Silva EG .2005 .Undifferentiated carcinoma of the endometrium. Am J Surg Pathol, 29(10) : 1316-21.
Al-Hussaini M,Lataifeh I,Jaradat I,Abdeen G,Otay L,Badran O .2018 .Undifferentiated endometrial carcinoma, an immunohistochemical study including PD-L1 testing of a series of cases from a single cancer center. Int J Gynecol Pathol, 37(6) : 564-74.
Üreyen I,Ilgin H,Turan T,Taşçi T,Karalök A,Boran N,Elson P,Rybicki L,Amarnath S,Yang B,Michener CM .2019 .Undifferentiated endometrial carcinoma: a National Cancer Database analysis of prognostic factors and treatment outcomes. Int J Gynecol Cancer, 29(7) : 1126-33.
Gracia M,Yildirim Y,Macuks R,Mancari R,AchimasCadariu P,Polterauer S .2023 .Influence of clinical and surgical factors on uterine carcinosarcoma survival. Cancers, 15(5) : 1463.
Chiang CY,Huang HJ,Chang WY,Yang LY,Wu RC,Wang CC .2021 .Adjuvant therapy and prognosis in uterine carcinosarcoma. J Formos Med Assoc, 120(11) : 1977-87.
Bosquet JG,Terstriep SA,Cliby WA,Brown-Jones M,Kaur JS,Podratz KC .2010 .The impact of multi-modal therapy on survival for uterine carcinosarcomas. Gynecol Oncol, 116(3) : 419-23.
.2024 .. 2024 Revised: September, 25 : .
0

Citations

0

Downloads

48

Views